Endocrinology
Conference Coverage
Dalcetrapib Boosts HDL Without Benefiting Patients
Major Finding: After a median 31 months, patients treated with dalcetrapib or placebo showed no significant difference in primary end point events...
News
Vitamin D Assays Flawed, but Improving
Conference Coverage
DPP-4 Inhibitors for Diabetes May Cut Cardiovascular Risk
Major Finding: Patients on a dipeptidyl peptidase-4 inhibitor to treat their type 2 diabetes had a 49% reduction in the composite end point of...
Conference Coverage
In Type 1 Diabetes, Cardiac Measures Improved After Pancreas Transplant
Major Finding: Cardiac morphology and function improved significantly after pancreas-only transplant: Posterior wall thickness and...
Commentary
Statins Sever the Diabetes and Coronary Disease Link
Conference Coverage
Acetaminophen-Linked Liver Failure Risk Heightened in Bariatric Surgery Patients
Major Finding: Among patients with acute liver failure from acetaminophen, the prevalence of prior bariatric surgery was 25-fold higher than in...
News
Insulin Degludec's Long Duration Sways FDA Panel
News
New Assay Simultaneously Measures Vitamin D Metabolites
Major Finding: The limit of detection in the assay for 24,25(OH)2D3 was 0.08 ng/mL; the limit for 24,25(OH)2D2 was 0.5 ng/mL.Data Source: Data are...
News
FDA Panel Backs Somatostatin Analogue for Cushing's
Conference Coverage
Merkel Cell Carcinoma Prognosis Linked to Vitamin D
Major Finding: Vitamin D deficiency was found in nearly two-thirds of a large group of patients with Merkel cell carcinoma, and their outcomes...
News
Aliskiren Didn't Protect Heart, Kidneys in Diabetes
Major Finding: After 33 months’ follow-up, 18% of patients taking aliskiren and 17% of placebo patients experienced a serious cardiovascular or...